Stratex International unveils new alliance with Centerra subsidiary

Stratex International, the AIM-listed exploration and development company focused on gold and base metals in Turkey, East and West Africa, has formed a strategic alliance with a subsidiary of the North America-based gold mining company Centerra Gold, to explore for gold in central Turkey.

Stratex International, the AIM-listed exploration and development company focused on gold and base metals in Turkey, East and West Africa, has formed a strategic alliance with a subsidiary of the North America-based gold mining company Centerra Gold, to explore for gold in central Turkey.

Under the terms of the arrangement, Centerra will fund a strategic alliance programme to explore for new gold projects in central Turkey.

This will include $500,000 in year one with an option each year to fund further work for at least $250,000 per annum.

Centerra will have the option to earn to 51% of any designated project area by funding $1.0m for exploration and development within two years of Centerra's election and Stratex will have the right to maintain a 49% interest by funding future exploration and development on a pro rata basis.

Dr Bob Foster, Chief Executive Officer of Stratex, commented: "Over the past three years we have developed an excellent working relationship with Centerra and we relish the opportunity to develop this association further.

"Our respective technical teams have a high degree of mutual respect as well as excellent track records, and this new alliance can only be for the considerable benefit of both companies."

Stratex' share price was unchanged at 4.38p at 08:36 on Tuesday.

MF

Recommended

Imperial Brands has an 8.3% yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% yield – but what’s the catch?

Tobacco company Imperial Brands boasts an impressive dividend yield, and the shares look cheap. But investors should beware, says Rupert Hargreaves. H…
20 May 2022
Investing in drugmakers: uncommon profits from curing rare diseases
Share tips

Investing in drugmakers: uncommon profits from curing rare diseases

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022
Delivering profits: should you buy Royal Mail shares?
Share tips

Delivering profits: should you buy Royal Mail shares?

The volume of parcels delivered by Royal Mail soared during the pandemic, and so did its profits. But it has been coming under pressure lately. So, as…
19 May 2022

Most Popular

The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
18 May 2022
Aviva: a share for income investors to tuck away
Share tips

Aviva: a share for income investors to tuck away

Insurance giant Aviva is one of the highest yielding stocks in the FTSE 100 – and it’s cheap, too, making it a tempting target for income investors. R…
18 May 2022
Despite the crypto crash, bitcoin still has a bright future
Bitcoin & crypto

Despite the crypto crash, bitcoin still has a bright future

Cryptocurrencies have crashed hard, with bitcoin down by more than 50% from its peak. But, says Dominic Frisby, bitcoin still has a future – it is the…
19 May 2022